Overcoming resistance to colon cancer treatment

byUniversity of GenevaColorectal cancer cells after treatment with FOLFOXIRI chemotherapy for 34 weeks. Cell fibers (in green) and nuclei (in blue). Credit: UNIGE-Nowak-SliwinskaColorectal cance

Updated on: December 28,2023 10

Overcoming resistance to colon cancer treatment

byUniversity of GenevaColorectal cancer cells after treatment with FOLFOXIRI chemotherapy for 34 weeks. Cell fibers (in green) and nuclei (in blue). Credit: UNIGE-Nowak-SliwinskaColorectal cance

Updated on:December 28,2023 10

Cancer research explores role of cytochrome oxygenases in augmenting austocystin D-mediated cytotoxicity

byTokyo University of SciencePrevious studies have suggested that austocystin D is oxidized by cytochrome P450 (CYP) oxygenases which then induces DNA damage and suppresses cell proliferation. I

Updated on: September 06,2024 0

Cancer research explores role of cytochrome oxygenases in augmenting austocystin D-mediated cytotoxicity

byTokyo University of SciencePrevious studies have suggested that austocystin D is oxidized by cytochrome P450 (CYP) oxygenases which then induces DNA damage and suppresses cell proliferation. I

Updated on:September 06,2024 0

Researchers developing test for early breast lesions

by Angela Koenig,University of Cincinnati Academic Health CenterWeber's research has made key contributions to understanding the molecular mechanisms of metastasis. Credit: University of Cin

Updated on: June 01,2024 7

Researchers developing test for early breast lesions

by Angela Koenig,University of Cincinnati Academic Health CenterWeber's research has made key contributions to understanding the molecular mechanisms of metastasis. Credit: University of Cin

Updated on:June 01,2024 7

Are the benefits of new cancer drugs worth the cost?

by Sbarro Health Research Organization (SHRO)The rate of growth in costs (red) vs. outcomes (green) of cancer care, is here expressed as the derivative D[fx0] of both functions (i.e.: the angular coef

Updated on: January 12,2024 10

Are the benefits of new cancer drugs worth the cost?

by Sbarro Health Research Organization (SHRO)The rate of growth in costs (red) vs. outcomes (green) of cancer care, is here expressed as the derivative D[fx0] of both functions (i.e.: the angular coef

Updated on:January 12,2024 10

Scientists unravel mystery of drug response in small cell lung cancer

by University of CologneTumor samples and clinical history of 65 patients with SCLC. a, Tumor sites sampled from 65 patients with SCLC. Frequently sampled sites are highlighted in bold. Tumors we

Updated on: March 20,2024 16

Scientists unravel mystery of drug response in small cell lung cancer

by University of CologneTumor samples and clinical history of 65 patients with SCLC. a, Tumor sites sampled from 65 patients with SCLC. Frequently sampled sites are highlighted in bold. Tumors we

Updated on:March 20,2024 16

Noninvasive technology for the high-throughput characterization of cancer cells

byTokyo University of ScienceSchematic of a cell rotation movement in a rotating AC electric field for (a) conventional ROT and (b) newly developed cROT. In conventional ROT in (a), when AC volt

Updated on: January 02,2024 20

Noninvasive technology for the high-throughput characterization of cancer cells

byTokyo University of ScienceSchematic of a cell rotation movement in a rotating AC electric field for (a) conventional ROT and (b) newly developed cROT. In conventional ROT in (a), when AC volt

Updated on:January 02,2024 20

Liver cancer deaths climb by around 50% in the last decade

by Cancer Research UKA graph showing liver cancer mortality. Credit: Cancer Research UKLiver cancer deaths have increased by around 50% in the last decade and have tripled since records began, ac

Updated on: April 23,2024 15

Liver cancer deaths climb by around 50% in the last decade

by Cancer Research UKA graph showing liver cancer mortality. Credit: Cancer Research UKLiver cancer deaths have increased by around 50% in the last decade and have tripled since records began, ac

Updated on:April 23,2024 15

Clonal hematopoiesis may be more common among pediatric cancer survivors than the general population

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainResearchers identified a higher rate of clonal hematopoiesis (CH) and prevalence of treatment-induced STAT3 gene mutat

Updated on: December 28,2023 10

Clonal hematopoiesis may be more common among pediatric cancer survivors than the general population

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainResearchers identified a higher rate of clonal hematopoiesis (CH) and prevalence of treatment-induced STAT3 gene mutat

Updated on:December 28,2023 10

Blood tests could offer smarter treatment for children's cancer

byInstitute of Cancer ResearchRhabdomyosarcoma cells. Credit: Dr Ewa Aladowicz, ICRA simple blood test could help guide the treatment of children with the cancer rhabdomyosarcoma, a new study re

Updated on: January 15,2024 18

Blood tests could offer smarter treatment for children's cancer

byInstitute of Cancer ResearchRhabdomyosarcoma cells. Credit: Dr Ewa Aladowicz, ICRA simple blood test could help guide the treatment of children with the cancer rhabdomyosarcoma, a new study re

Updated on:January 15,2024 18

Researchers identify a protein that promotes cancer metastasis, providing a new potential treatment target

by City University of Hong KongThey also demonstrated that LH1 could bind and stabilize Septin2 (SEPT2), a protein that plays an essential role in preparing the cells for high mechanical migratio

Updated on: February 24,2024 15

Researchers identify a protein that promotes cancer metastasis, providing a new potential treatment target

by City University of Hong KongThey also demonstrated that LH1 could bind and stabilize Septin2 (SEPT2), a protein that plays an essential role in preparing the cells for high mechanical migratio

Updated on:February 24,2024 15

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on: July 10,2024 0

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on:July 10,2024 0

What causes breast cancer?

by Annika Lund,Karolinska InstitutetMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumor beyond the lymph node. Credit: Nephron/WikipediaThere is a lot

Updated on: March 30,2024 0

What causes breast cancer?

by Annika Lund,Karolinska InstitutetMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumor beyond the lymph node. Credit: Nephron/WikipediaThere is a lot

Updated on:March 30,2024 0